Physician profile
William James Hozack
NPI 1497709075
$10,649,247.18
in general payments reported to CMS, 2019-2025
11 companies · $1.9M in 2025
The $1.9M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1.4M · 2020: $1.2M · 2021: $1.4M · 2022: $1.4M · 2023: $1.6M · 2024: $1.7M · 2025: $1.9M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $5.2M · Travel and Lodging: $24K · Consulting Fee: $23K · Food and Beverage: $6,801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $5,154,135.87 |
| Travel and Lodging | $23,709.59 |
| Consulting Fee | $22,500.00 |
| Food and Beverage | $6,801.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $10,648,267.25 | 2019-2025 | Accolade, Trident, Triathlon |
| Zimmer Biomet Holdings, INC. | $190.03 | 2023-2025 | Gel-One Cross-Linked Hyaluronate |
| Paladin Technology Solutions | $156.50 | 2023-2024 | |
| Smith+Nephew, INC. | $146.34 | 2021 | |
| Acumed LLC | $122.43 | 2024 | Acumed, Inframe Implant |
| Davol INC. | $116.53 | 2021 | |
| Skeletal Dynamics INC | $96.97 | 2021 | |
| Encore Medical, Lp | $83.67 | 2019-2023 | Djo Surgical |
| Si-Bone, INC. | $29.09 | 2023 | |
| Microport Orthopedics INC | $23.19 | 2022 | |
| Depuy Synthes Sales INC. | $15.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hozack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.